Literature DB >> 6372895

Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow.

D S Bross, P J Tutschka, E R Farmer, W E Beschorner, H G Braine, E D Mellits, W B Bias, G W Santos.   

Abstract

To identify predictive parameters for incidence and severity of acute graft-versus-host disease (GVHD), 136 patients, transplanted with histocompatible marrow as therapy for aplastic anemia and hematologic malignancies, were examined using univariate and multivariate analyses. The risk of GVHD increased in patients with acute lymphocytic leukemia (p less than 0.05), in sex-mismatched donor-recipient pairs (p less than 0.01), and in patients older than 23.7 yr (p less than 0.05). No other commonly observed factors appeared to have any relationship to GVHD except the presence of certain alleles. The presence of a Cw4 allele or of the Bw21 specificities B49 and B50 were associated with significantly increased risks of GVHD (p less than 0.05), whereas the presence of Aw19 (or the related specificities A29, Aw30, Aw31 , Aw32, Aw33 ) was associated with a significantly decreased risk (p less than 0.01). Using these factors, a regression equation can be constructed that estimates the risk of a given patient to develop clinically significant acute GVHD.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372895

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  The association of HLA antigen and GVHD in allogeneic hemopoietic stem cell transplantation with histocompatible sibling donor: a single-center experience in Korea.

Authors:  Hee Je Kim; Soo Jeong Park; Hyun Woo Im; Dong Wook Kim; Woo Sung Min; Hack Ki Kim; Won Il Kim; Kwang Sung Kim; Chun Choo Kim
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

Review 2.  Genetics of graft-versus-host disease: the major histocompatibility complex.

Authors:  Effie W Petersdorf
Journal:  Blood Rev       Date:  2012-11-20       Impact factor: 8.250

Review 3.  Current thoughts on the pathogenesis of graft versus host disease.

Authors:  A L Appleton; L Sviland
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

4.  CD57+ T cells augment IFN-gamma production in a one-way mixed lymphocyte reaction and their expansion after stem cell transplantation in paediatric patients.

Authors:  Y Koike; S Seki; T Ohkawa; T Kaneko; K Kogawa; S Fujitsuka; H Hiraide; I Sekine
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

Review 5.  Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies.

Authors:  Stefan O Ciurea; Richard E Champlin
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-11       Impact factor: 5.742

6.  Donor-recipient gender difference affects severity of dry eye after hematopoietic stem cell transplantation.

Authors:  M Kamoi; Y Ogawa; M Uchino; Y Tatematsu; T Mori; S Okamoto; K Tsubota
Journal:  Eye (Lond)       Date:  2011-04-08       Impact factor: 3.775

Review 7.  Prevention and management of graft-versus-host disease. Practical recommendations.

Authors:  G B Vogelsang; L E Morris
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

Review 8.  Bone marrow transplantation for acute lymphoblastic leukemia (ALL).

Authors:  H M Lazarus; J M Rowe
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

9.  Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease.

Authors:  D Zeng; D Lewis; S Dejbakhsh-Jones; F Lan; M García-Ojeda; R Sibley; S Strober
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

10.  Impact of Human Leukocyte Antigen Loci and Haplotypes on Intestinal Acute Graft-versus-host Disease after Human Leukocyte Antigen-matched Sibling Peripheral Blood Stem Cell Transplantation.

Authors:  Fa-Hong Yan; Mei Wang; Jian-Feng Yao; Er-Lie Jiang; Ming-Zhe Han
Journal:  Chin Med J (Engl)       Date:  2017-06-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.